If approved, MCO-010 would be the first treatment to restore vision in legally blind RP patients without needing genetic ...

Swiss clinical-stage CNS disease specialist Synendos Therapeutics has named Dr George Garibaldi as its chief medical officer ...

USA-based Uniquity Bio has appointed industry veteran Will Kane as its president and chief executive. The clinical-stage drug ...

San Diego, USA-based Neurocrine Biosciences on Monday reported new positive data from the Phase III CAHtalyst Adult study of ...

US biotech major Vertex Pharmaceuticals (Nasdaq: VRTX) has reached a wide-ranging reimbursement deal with NHS England for ...

Indian drugmaker Sun Pharmaceutical Industries together with its subsidiaries announced that further to its intimation dated ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of Lynkuet (elinzanetant) for the ...

A quiet shift with potentially big implications for cancer drug access is underway in the UK. In June, the country’s health ...

Germany’s Bayer has announced that the US Food and Drug Administration (FDA) has approved Kerendia (finerenone) to treat ...

Japan’s largest pharma company Taked today announced that all primary and secondary endpoints were met in two Phase III ...

The Flamma Group has celebrated the grand opening of its new cGMP plant in Dalian, China. A contract development and ...

The Amsterdam District Court has delivered a ruling in the lawsuit brought by Farma ter Verantwoording (FtV) — The ...